The U.S. has shipped over half a million doses of antibody treatments that have the potential to keep high-risk Covid patients out of hospitals if given early enough in their infection.
This would help already overburdened hospitals avoid additional strain, but the drugs are still being underutilized despite their promising results, Trump administration health officials said Thursday. That’s because many patients don’t know how to access them, and hospitals aren’t prescribing the medications or arranging the infusion sites necessary to administer the drugs, they said.
